BEGHETTO, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 8.291
EU - Europa 4.731
AS - Asia 3.629
SA - Sud America 476
Continente sconosciuto - Info sul continente non disponibili 127
AF - Africa 74
OC - Oceania 4
Totale 17.332
Nazione #
US - Stati Uniti d'America 8.047
IT - Italia 1.939
GB - Regno Unito 1.066
CN - Cina 1.043
SG - Singapore 1.011
SE - Svezia 442
BR - Brasile 378
HK - Hong Kong 371
VN - Vietnam 335
DE - Germania 302
TR - Turchia 229
BD - Bangladesh 180
UA - Ucraina 180
FI - Finlandia 177
FR - Francia 152
RU - Federazione Russa 146
CA - Canada 121
IN - India 107
KR - Corea 107
NL - Olanda 68
BG - Bulgaria 61
MX - Messico 41
IL - Israele 39
AR - Argentina 35
ID - Indonesia 33
PL - Polonia 25
IQ - Iraq 24
ES - Italia 22
LT - Lituania 22
IE - Irlanda 21
CR - Costa Rica 19
IR - Iran 19
CO - Colombia 18
PK - Pakistan 18
BE - Belgio 17
SA - Arabia Saudita 16
ZA - Sudafrica 15
JM - Giamaica 14
CH - Svizzera 13
JP - Giappone 13
EC - Ecuador 12
SI - Slovenia 12
AT - Austria 11
EU - Europa 11
TT - Trinidad e Tobago 11
GT - Guatemala 10
MA - Marocco 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
TH - Thailandia 9
DZ - Algeria 8
MY - Malesia 8
PH - Filippine 8
CZ - Repubblica Ceca 7
EG - Egitto 7
NG - Nigeria 7
UZ - Uzbekistan 7
VE - Venezuela 7
GR - Grecia 6
JO - Giordania 6
PE - Perù 6
RO - Romania 6
SC - Seychelles 6
BY - Bielorussia 5
DK - Danimarca 5
HN - Honduras 5
KE - Kenya 5
KZ - Kazakistan 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
AU - Australia 4
DO - Repubblica Dominicana 4
GE - Georgia 4
NI - Nicaragua 4
NP - Nepal 4
PA - Panama 4
RS - Serbia 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
CW - ???statistics.table.value.countryCode.CW??? 3
EE - Estonia 3
PR - Porto Rico 3
SN - Senegal 3
SV - El Salvador 3
AM - Armenia 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CU - Cuba 2
CY - Cipro 2
ET - Etiopia 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MG - Madagascar 2
PT - Portogallo 2
QA - Qatar 2
Totale 17.201
Città #
Ashburn 1.371
Santa Clara 787
Southend 781
Singapore 678
Woodbridge 461
San Jose 392
Fairfield 389
Chandler 385
Hong Kong 364
Jacksonville 326
Hefei 285
Ann Arbor 251
Houston 243
Beijing 236
Nyköping 235
Dearborn 223
Council Bluffs 204
Milan 188
Rome 186
Wilmington 186
London 151
Cambridge 143
Seattle 141
Dallas 138
Los Angeles 130
Izmir 123
Helsinki 110
Seoul 105
Ho Chi Minh City 95
New York 89
Buffalo 88
The Dalles 84
São Paulo 80
Naples 78
Hanoi 72
Princeton 70
Chicago 66
Modena 58
San Diego 58
Sofia 58
Eugene 57
Frankfurt am Main 57
Lauterbourg 48
Toronto 45
Shanghai 44
Munich 38
Bari 36
Moscow 34
Palermo 34
Bologna 33
Florence 33
Des Moines 30
Columbus 27
Da Nang 26
Orem 26
Atlanta 24
Catania 23
Chennai 23
Turin 23
Brescia 22
Philadelphia 22
Montreal 20
Guangzhou 19
Mexico City 18
Dublin 17
Mumbai 17
Boardman 16
Brooklyn 16
Brussels 16
Elk Grove Village 16
San José 16
Warsaw 16
Falkenstein 15
Jakarta 15
Memphis 15
Phoenix 15
Salt Lake City 15
Nanjing 14
Augusta 13
Boston 13
Bremen 13
Haiphong 13
San Mateo 13
Turku 13
Baghdad 12
Denver 12
Johannesburg 12
Manassas 12
Stockholm 12
Genoa 11
Kent 11
Norwalk 11
Ottawa 11
Redwood City 11
Ferrara 10
Kunming 10
Mashhad 10
Parma 10
Shenzhen 10
Tokyo 10
Totale 11.342
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.970
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 392
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 385
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients 371
Associatioin of epicardial adipose tissue with incident coronary heart disease and death in HIV infected patients. 342
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 337
Effectiveness and durability of polyacrylamide hydrogel injections for treating HIV-related facial lipoatrophy 331
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 330
A randomized, controlled trial to evaluate change in cardiometabolic and endothelial function in HIV-infected patients with optimal viral suppression on Darunavir/ritonavir monotherapy vs. triple-therapy. 330
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 328
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 317
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 317
Detectable HIV viral load is associated with metabolic syndrome 316
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 314
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 313
Prediction of hard cardiovascular events in HIV patients 302
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection 293
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 290
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 289
Severity of lipodystrophy is associated with decreased health-related quality of life 289
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 288
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 274
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 272
Prevalence and risk factors of pubic lipomas in HIV-infected patients 269
Age-related comorbidities in people living with HIV 269
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV 269
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 265
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 259
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 259
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 255
ISS-NIA ITALIAN COHORT: NEW ANTI-HIV INHIBITORS IN PATIENTS EXPERIENCED TO IP, NRTI, NNRTI. 253
How do frailty mediate pathway leading to disability 252
Randomized Trial to Evaluate Cardiometabolic and Endothelial Function in Patients with Plasma HIV-1 RNA Suppression Switching to Darunavir/Ritonavir with or without Nucleoside Analogues 251
Virologic failure and metabolic syndrome in patients with HIV infection 251
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 245
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 244
Does lipodistrophy affect quality of life? 242
Body Image perception in HIV infected women with body fat redistribution. 241
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 240
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study 231
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the italian version of assessment of body change and distress questionnaire 222
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 218
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 216
È possibile un counselling HIV su internet? 215
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 213
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 212
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial 209
Validity of body image perception in women with HIV. 209
Lipodystrophy and quality of life: a prospective study 208
Metabolic and anthropometric alterations in a population of HIV infected patients with a high prevalence of lipodystrophy: associations with HCV coinfection 200
Virologic failure and metabolic syndrome in patients with HIV infection 197
Prospective, 48 weeks follow up, multidisciplinary interventionalstudy to assess improvement of adherence in people with lipodistrophy. 195
Relapse of HIV-related buffalo hump after liposuction 192
Ruolo della chirurgia plastica nel trattamento della sindrome da ridistribuzione del tessuto adiposo 188
Qual è il rapporto tra qualità di vita e lipodistrofia 184
HIV counselling looks for new target and methods web versus face to face counselling 176
Nuovi obiettivi e strumenti di lavoro nel counselling HIV: studio prospettico osservazionale del counselling informatico versus il counselling vis a vis 170
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 164
Gender differences in depression evolution in a cohort of patients attendine a metabolic clinic for lipodystrophy management 159
Lipodistrophy is related to adherence to antiretroviral therapy (ARV) 153
HIV counselling and prevention on the WEB 147
Totale 17.332
Categoria #
all - tutte 56.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.928


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022591 0 0 0 0 23 43 34 76 95 66 142 112
2022/20231.398 140 121 111 109 121 178 38 152 180 45 107 96
2023/20241.039 60 71 81 130 165 79 91 98 34 49 60 121
2024/20252.816 113 77 60 224 589 403 214 130 336 97 259 314
2025/20264.666 309 222 473 544 541 346 508 268 498 420 281 256
2026/20272.160 165 325 526 1.042 102 0 0 0 0 0 0 0
Totale 17.332